Evidence map›Paper›PMID 36032159›Full record

ReviewFrontiers in immunology2022

Defying convention in the time of COVID-19: Insights into the role of γδ T cells.

Marta Sanz, Brendan T Mann, Alisha Chitrakar, Natalia Soriano-Sarabia

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Marta SanzDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, United States.
Brendan T MannDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, United States.
Alisha ChitrakarDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, United States.
Natalia Soriano-SarabiaDepartment of Microbiology, Immunology and Tropical Medicine, George Washington University, Washington, DC, United States.
George Washington University · US

Funding

Peripheral and tissue-resident gamm/delta T cells in HIV latencyR01AI125097 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SORIANO-SARABIA, NATALIA · 2016 to 2020
$2.7M
Allogeneic cytotoxic gammadelta T cells for HIV cure immunotherapyR21AI157864 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI SORIANO-SARABIA, NATALIA · 2021 to 2022
$436k
NIAID NIH HHS R01 AI125097NIAID NIH HHS R21 AI157864
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 is a complex disease which immune response can be more or less potent. In severe cases, patients might experience a cytokine storm that compromises their vital functions and impedes clearance of the infection. Gamma delta (γδ) T lymphocytes have a critical role initiating innate immunity and shaping adaptive immune responses, and they are recognized for their contribution to tumor surveillance, fighting infectious diseases, and autoimmunity. γδ T cells exist as both circulating T lymphocytes and as resident cells in different mucosal tissues, including the lungs and their critical role in other respiratory viral infections has been demonstrated. In the context of SARS-CoV-2 infection, γδ T cell responses are understudied. This review summarizes the findings on the antiviral role of γδ T cells in COVID-19, providing insight into how they may contribute to the control of infection in the mild/moderate clinical outcome.

Indexed as

COVID-19Immunity, InnateT-Lymphocyte SubsetsAntiviral AgentsCytokinesHumansReceptors, Antigen, T-Cell, gamma-deltaSARS-CoV-2Antiviral AgentsCytokinesReceptors, Antigen, T-Cell, gamma-deltaaminobisphosphonates COVID-19COVID-19gamma delta (γδ) T cellsinnate immunitySARS-CoV-2

Identifiers

PMID36032159
PMCPMC9403327
OpenAlexW4292729110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.